Precigen, Inc. (PGEN) Financials

PGEN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 170.3 million 126.7 million
March 31, 2026 138.6 million 118.4 million
Dec. 31, 2025 156.6 million 135.7 million
Sept. 30, 2025 171.3 million 129.4 million

PGEN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -18.2 million 3.6 million
March 31, 2026 -44.1 million 3.0 million
Dec. 31, 2025 -24.1 million 2.2 million
Sept. 30, 2025 -29.5 million 4.4 million

PGEN Net Income

No data available :(

PGEN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 38.2 million 93.9 million 4.5 million
March 31, 2026 56.2 million 93.5 million 3.7 million
Dec. 31, 2025 97.9 million 93.2 million 5.1 million
Sept. 30, 2025 121.1 million 92.9 million 5.3 million

PGEN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 413.7 million
March 31, 2026 313.0 million
Dec. 31, 2025 313.0 million
Sept. 30, 2025 296.4 million

PGEN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 392000 7.3 million 22.2 million -
March 31, 2026 258000 5.3 million 21.0 million -
Dec. 31, 2025 622000 6.7 million 17.6 million -
Sept. 30, 2025 389000 12.1 million 24.0 million -

PGEN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 55.0 million 2.8 million
March 31, 2026 23.3 million 2.9 million
Dec. 31, 2025 4.6 million 1.9 million
Sept. 30, 2025 2.9 million 1.4 million

PGEN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PGEN

Price: $6.10

52 week price:
1.70
7.32

Payout Ratio Range:
-244.87%
-0.02%

Earnings Per Share: -1.07 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 4.3 million

Market Capitalization: 2.6 billion

Links: